According to a new report, published by KBV research, The Global Proton Therapy Market size is expected to reach $963.6 million by 2028, rising at a market growth of 12.5% CAGR during the forecast period.
The Beam Delivery System market is experiencing a CAGR of 12.7% during (2022 - 2028). The major goal of the beam-transport system is to apply the proper dose distribution to the patient's tumor while aiming the proton beam at it with the proper diameter and intensity. Transfer of the beam from the accelerator to the patient's tumor. In a proton therapy facility, the beam conveyance mechanism between the accelerator and the patient treatment area is explained.
The CNS Cancer market is leading the Global Proton Therapy Market by Indication in 2021; thereby, achieving a market value of $354 million by 2028. Due to a growth in CNS cancer prevalence and a surge in the preference for cutting-edge treatments among medical experts. A CNS tumor starts when normal cells in the spinal cord or brain transform and expand uncontrollably, generating a mass. Both forms of CNS tumors have the potential to be dangerous: malignant and benign.
The Proton Therapy Centers market would witness a CAGR of 12.7% during (2022 - 2028). A number of Proton Therapy Center patients maintain a healthy lifestyle during and after proton therapy treatment. Modern radiation therapy offers the broadest spectrum of cancer treatments with little toxicity and tissue damage to healthy tissue. Patients continue to work and work out while receiving proton therapy.
The North America market dominated the Global Proton Therapy Market by Region in 2021 thereby, achieving a market value of $370.6 million by 2028. The Europe market is exhibiting a CAGR of 12.2% during (2022 - 2028). Additionally, The Asia Pacific market is poised to grow at a CAGR of 13.3% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/proton-therapy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.
By Product Type
By Indication
By End User
By Geography
Companies Profiled
Unique Offerings 
